Biological and biotechnological products are at risk from viruses. With such products the potential for transmission of viral diseases is a real risk. Contamination can affect raw materials, cell culture processes, bioreactor contamination and downstream processing. It is for these reasons that organizations need to practice viral safety and control. In addition, a science-based testing regime must be in place.

It is also important to incorporate virus clearance into the manufacturing process. This webinar discusses the essential elements of control, testing, and remediation and it includes a spotlight on the main viruses of concern.

In this webinar you’ll learn: 

• Primary risks to biopharmaceutical processing from viruses
• The methods that can be implemented to control and remove viruses
• The test methods and testing strategy

• Biotechnologists
• Biopharmaceutical professionals
• R&D scientists
• Microbiologists
• Contamination control experts
• Manufacturing managers
• Quality Control / Quality Assurance 
• Analytical Development Scientists